ORBITAL THERAPEUTICS
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Feb 2031: the §8 declaration of use).
Record
- Serial number
- 97482263
- Registration number
- 7706969
- Mark type
- Word mark
- Filed
- 29 Jun 2022
- Published for opposition
- 29 Aug 2023
- Registered
- 25 Feb 2025
- Next maintenance filing
- §8 declaration of use, due by 25 Feb 2031 (grace period to 25 Aug 2031)
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the fields of health, medicine, biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids
Owner
- Orbital Therapeutics, Inc., Cambridge, MA, US
- Orbital Therapeutics, Inc., Cambridge, MA, US
- Orbital Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 30 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Apr 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Apr 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Apr 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Apr 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 05 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Jan 2025 — ASSIGNED TO LIE
- 23 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Oct 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED